ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fighting Heartburn and Gerd Naturally – And Safely!

Natural Bladder Control, Go Less and Live More

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Trimming the spare tire: Canola oil may cut belly fat

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

The Onion: Cancer Fighter and Food Preserver

Probiotics improve cognition in Alzheimer's patients

Curcumin Reverses the Cellular Damage of Chronic Stress

 
Print Page
Email Article

Melatonin-Based Compound Judged an Advance in Depression Therapy

  [ 18 votes ]   [ Discuss This Article ]
www.ProHealth.com • June 1, 2011


“Agomelatine is currently approved in the EU, US and Australia, and represents a significant step forward in the approach to the treatment of depression and other mood disorders."

Agomelatine, a unique chemical variation on melatonin, emerged the winner in a recent depression therapy investigation at two Australian research centers.

The investigation – which focused on comparing the effects of melatonin and several melatonin ‘analogue’ compounds – suggested that agomelatine shows particular promise as an advance in antidepressant therapy for two reasons.

• It provides levels of antidepressant activity similar to those of some widely used depression drugs.

• And, like the nutrient melatonin which is known for its ability to support regulation of the body’s internal sleep-wake clock (circadian system), agomelatine improves the sleep-wake patterns of those treated.

The investigation of melatonin and its relatives, reported online May 18 by the Lancet (“Novel melatonin-based therapies: Potential advances in the treatment of major depression”) was a natural step forward for mental health research, the authors say.

“Although available drugs are effective, they also have substantial limitations. Recent advances in our understanding of the fundamental links between chronobiology and major mood disorders, as well as the development of new drugs that target the circadian system, have led to a renewed focus on this area," say researchers Ian B Hickie, at the University of Sydney’s Brain & Mind Research Institute, and Naomi L Rogers, at Central Queensland University.

The paper says there is clear evidence that there are strong links between circadian disturbance and some of the most characteristic symptoms of clinical depression, including delayed sleep onset, non-restful sleep, early-morning wakening, daytime fatigue, and blunting or reversal of the normal morning peaks in subjective energy, mood, and alertness.

Most patients with depression have prolonged sleep latencies and a high frequency of arousals and awakenings during the night, Hickie and Rogers note. Consequently, sleepiness, daytime fatigue, or napping might be prominent.

Comparing Melatonin and Its Sister Compounds

Although melatonin and its sister compounds bind to the same receptor sites in the brain, they have a different affinity for these sites, the authors explain.

So they compared melatonin, ramelteon, tasimelteon, PD-6735, and agomelatine - and found agomeltatine to be the analogue with the most potential to help depressed patients.

They believe the antidepressant effects of agomelatine may be due to its unique combination of binding to melatonin receptors and blocking serotonin receptors in the brain.

• "In the short-term, agomelatine has similar antidepressant efficacy to venlafaxine, fluoxetine, and sertraline,”

• "And, in the longer term, fewer patients on agomelatine relapse (24%) than do those receiving placebo (50%).

• "Patients with depression treated with agomelatine report improved sleep quality and reduced waking after sleep onset."

Less Potential for Side Effects

They conclude: "As agomelatine does not raise serotonin levels, it has less potential for the common gastrointestinal, sexual, or metabolic side-effects that characterise many other antidepressant compounds...

“Because of its favorable adverse effect and safety profile, and the potential to help to restore circadian function between depressive episodes, this drug might occupy a unique place in the management of some patients with severe depression and other major mood disorders."

They conclude that “Agomelatine is currently approved in the EU, US and Australia, and represents a significant step forward in the approach to the treatment of depression and other mood disorders."

Source: The Lancet news release, May 17, 2011, excerpted.




Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Herbal Rescue for High Blood Sugar Herbal Rescue for High Blood Sugar
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS
Live Without Anxiety or Stress Live Without Anxiety or Stress

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map